Seems the original tweet here by Matthew Johnson (lead researcher for psychedelics at Johns Hopkins University) is also pretty significant as it's apparently the first time the U.S Government has funded psychedelics research since the 1970's.
"Johns Hopkins has been studying the potential benefits of psilocybin for smoking cessation for years, publishing a study in 2014 with impressive results. Dr. Johnson and his colleagues have been continuing this work, pushing several psychedelic studies forward. Recently Johns Hopkins signed a 5-year collaborative research agreement with Mydecine, and will take part in the company’s upcoming Phase 2/3 trial of psilocybin for nicotine addiction"
IHL Price at posting:
37.5¢ Sentiment: Hold Disclosure: Held